AtonRa Partners »

Intra Cellular Therapies shares owned by AtonRa Partners

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by AtonRa Partners from 13F filings

Historical chart of AtonRa Partners investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by AtonRa Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by AtonRa Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $413k 5.8k 71.62
2023-09-30 $330k 6.3k 52.09
2023-06-30 $495k 7.8k 63.32
2023-03-31 $463k 8.5k 54.15
2022-12-31 $503k 9.5k 52.92
2022-09-30 $561k 12k 46.51
2022-06-30 $698k 12k 57.11

More positions owned by AtonRa Partners

Dex (DXCM)
CrowdStrike Holdings Cl A (CRWD)
Shopify Cl A (SHOP)
Palantir Technologies Cl A (PLTR)
Transmedics Group (TMDX)
Coinbase Global Com Cl A (COIN)
Shift4 Payments Cl A (FOUR)
Block Com Cl A (XYZ)
Madrigal Pharmaceuticals (MDGL)
Schrodinger (SDGR)
Shockwave Med
Insulet Corporation (PODD)
Euronet Worldwide (EEFT)
Descartes Sys Grp (DSGX)
Affirm Holdings Com Cl A (AFRM)

View all positions for AtonRa Partners

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies